Skip to main content

DENTSPLY SIRONA Inc.

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

XRAY$9.54+0.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Changes in Equity

(in millions, except per share amounts)

CommonStockCapital inExcess ofPar ValueAccumulated DeficitAccumulatedOtherComprehensiveLossTreasuryStockTotal Dentsply SironaEquityNoncontrollingInterestsTotalEquity
Balance at December 31, 2025$3$6,644$(1,564)$(639)$(3,105)$1,339$1$1,340
Net loss——(10)——(10)—(10)
Other comprehensive (loss) income———(16)—(16)—(16)
Stock-based compensation expense—8———8—8
Funding of employee stock purchase plan—(5)——61—1
Restricted stock unit distributions—(31)——27(4)—(4)
Balance at March 31, 2026$3$6,616$(1,574)$(655)$(3,072)$1,318$1$1,319
Net income (loss)——37——37(1)36
Other comprehensive (loss) income———(1)—(1)—(1)
Stock-based compensation expense—9———9—9
Treasury shares purchased————(12)(12)—(12)
Restricted stock unit distributions—(6)——6———
Balance at June 30, 2026$3$6,619$(1,537)$(656)$(3,078)$1,351$—$1,351
Net loss——(2)——(2)(1)(3)
Other comprehensive income———9—9—9
Exercise of stock options—(1)——1———
Stock-based compensation expense—8———8—8
Funding of employee stock purchase plan—(5)——72—2
Treasury shares purchased————(13)(13)—(13)
Restricted stock unit distributions—(2)——2———
Balance at September 30, 2026$3$6,619$(1,539)$(647)$(3,081)$1,355$(1)$1,354
CommonStock · Capital inExcess ofPar Value · Accumulated Deficit · AccumulatedOtherComprehensiveLoss · TreasuryStock · Total Dentsply SironaEquity · NoncontrollingInterests · TotalEquity
Balance at December 31, 2024$3$6,640$(835)$(730)$(3,136)$1,942$1$1,943
Net income (loss)——20——20(1)19
Other comprehensive loss———71—71—71
Stock-based compensation expense—10———10—10
Funding of employee stock purchase plan—(3)——52—2
Restricted stock unit distributions—(17)——14(3)—(3)
Restricted stock unit dividends—1(1)—————
Cash dividends declared ($0.16 per share)——(32)——(32)—(32)
Balance at March 31, 2025$3$6,631$(848)$(659)$(3,117)$2,010$—$2,010
Net (loss) income——(45)——(45)1(44)
Other comprehensive income———18—18—18
Stock-based compensation expense—9———9—9
Restricted stock unit distributions—(2)——2———
Cash dividends declared ($0.16 per share)——(32)——(32)—(32)
Balance at June 30, 2025$3$6,638$(925)$(641)$(3,115)$1,960$1$1,961
Net loss—(427)——(427)(1)(428)
Other comprehensive loss———(31)—(31)—(31)
Stock-based compensation expense—6———6—6
Funding of employee stock purchase plan—(4)——62—2
Restricted stock unit distributions—(3)——3———
Restricted stock unit dividends—1(1)—————
Cash dividends declared ($0.16 per share)——(32)——(32)—(32)
Balance at September 30, 2025$3$6,638$(1,385)$(672)$(3,106)$1,478$—$1,478
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.